Intracoronary Injection of Bone Marrow–Derived Mononuclear Cells Early or Late After Acute Myocardial Infarction: Effects on Global Left Ventricular Function

Study Questions:

What is optimal timing for treatment with bone-marrow mononuclear cells (BM-MNCs) for improvement of left ventricular (LV) function following myocardial infarction (MI)?